top of page
it's where dermatology lives
By John Evans
Apr 9, 20201 min read
Periostin activates itch response
“Periostin and its receptor connect the skin directly to the central nervous system,” said the study’s lead author, Santosh Mishra, PhD, in
by Cory Perla
Aug 21, 20191 min read
Study finds skin disease prurigo nodularis is often overlooked
A new study has found that prurigo nodularis (PN) may be more common than previously thought, but is often overlooked due to more serious co
Derm City
Mar 6, 20191 min read
Atopic dermatitis, not necessarily itch, can negatively effect sleep in children
Atopic dermatitis can have a negative effect on sleep quality in children. Though pruritus can be worse at night, scratching episodes accoun
by John Evans
Dec 14, 20182 min read
Treatments for prurigo nodularis reviewed
“By identifying which current and future therapies are effective for prurigo nodularis, we can gain a better understanding of the biological
by John Evans
Aug 17, 20182 min read
Experimental agent holds promise for treating chronic itch
In their experiments, the investigators were able to show that the experimental medication not only suppressed acute itch, but was also effe
by John Evans
Jun 15, 20182 min read
Prurigo nodularis more common in those of African descent
Study authors note the paper represents some of the first published reliable information from a racially diverse population about who likely
By John Evans
Nov 17, 20172 min read
Itch-related neurotransmitter plays no role in pain transmission
Ideally the goal would be to develop treatments that interrupt pain or itch closer to their source, said Dr. Mishra. “If we can block the se
By John Evans, Associate Editor
Mar 17, 20172 min read
Anti-IL-31 drug shows promise in itch management for atopic dermatitis
A phase-II study of a new systemic therapy for atopic dermatitis has found that the therapy, the anti-interleukin (IL)31 antibody...
Featured Posts
bottom of page